Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Protein tyrosine or serine/threonine kinase inhibitors in development at Novartis

June 1, 1998

Imutech and Harvard Medical School join forces for clotrimazole development

June 1, 1998

New protein farnesyltransferase inhibitors prepared by Zeneca

June 1, 1998

Somatostatin analogue TT-232 prevents proliferation of pancreatic cancer

May 29, 1998

Aphton describes efficacy of Gastrimmune at two major scientific meetings

May 29, 1998

Matrix receives patent protection for MPI-5020 and AccuSite

May 29, 1998

Biomira's lymphoma vaccine headed for phase I testing

May 29, 1998

Bristol-Myers Squibb presents derivatives of indolopyrrolocarbazoles as antitumor agents

May 29, 1998

CNI-1493 prevents IL-2 toxicity without affecting antitumor activity in rats

May 29, 1998

Reduction of colon cell proliferation associated with soy product consumption

May 29, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...